Citigroup’s Sensus Healthcare SRTS Stock Holding History

Citigroup’s Portfolio SRTS Stock Details SRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-25	Closed	-$79	–	6456
2025 Q3	$79	Buy	+25	New	+$98	﹤0.01%	5823
2022 Q4	–	Sell	-230	Closed	-$3K	–	5945
2022 Q3	$3K	Buy	+230	New	+$2.75K	﹤0.01%	5419

Other funds holding SRTS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PRCP

Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MIM

Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

GWM

Greenline Wealth Management Boca Raton, Florida $122M AUM

Citigroup's SRTS Position: Q4 2025 in Review

Citigroup sold out of Sensus Healthcare (SRTS) in Q4 2025, closing a stake of 25 shares — an estimated $79 sold.

Citigroup first reported a position in SRTS in Q3 2022 and held it in 2 quarters. The position peaked at $3K in Q3 2022. 45 funds tracked by Wall St. Rank hold SRTS as of Q4 2025.

Citigroup reported no remaining Sensus Healthcare position as of Q4 2025 after selling out during the quarter.
Citigroup sold 25 Sensus Healthcare shares in Q4 2025, an estimated $79.
Citigroup first reported a position in Sensus Healthcare in Q3 2022 and held it in 2 quarters.
Citigroup's Sensus Healthcare position peaked at $3K in Q3 2022.
45 funds tracked by Wall St. Rank held Sensus Healthcare as of Q4 2025.

Based on Citigroup's 13F filing for Q4 2025, filed 13 Feb 2026.